FAKTOR-OPTIONSSCHEIN - ASTRAZENECA | Market Closed - Deutsche Boerse AG 03:40:33 2024-07-12 pm EDT | ||
| 0.043 EUR | -8.51% |
|
| Current month | +7.50% | ||
| 1 month | +13.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.043 | -8.51% |
| 24-07-11 | 0.047 | -6.00% |
| 24-07-10 | 0.05 | -7.41% |
| 24-07-09 | 0.054 | +10.20% |
| 24-07-08 | 0.049 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update July 12, 2024 at 03:40 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
Société Générale
|
| WKN | SH8ETS |
| ISIN | DE000SH8ETS7 |
| Date issued | 2022-04-06 |
| Strike | 10,166 p |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.93 € |
|---|---|
| Lowest since issue | 0.031 € |
| Spread | 0.01 € |
| Spread % | 18.52% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
159.2
USD
Average target price
177.2
USD
Spread / Average Target
+11.26%
- Stock Market
- Certificates
- Certificat
